Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease
about
Anti-inflammatory drugs and risk of Parkinson disease: A meta-analysisNon-steroidal anti-inflammatory drugs as disease-modifying agents for Parkinson's disease: evidence from observational studiesUse of ibuprofen and risk of Parkinson diseaseInsights into Neuroinflammation in Parkinson's Disease: From Biomarkers to Anti-Inflammatory Based TherapiesNeuroinflammation in the pathophysiology of Parkinson's disease and therapeutic evidence of anti-inflammatory drugsM1 and M2 immune activation in Parkinson's Disease: Foe and ally?Brain arachidonic acid cascade enzymes are upregulated in a rat model of unilateral Parkinson diseaseCatalytic antioxidants and neurodegenerationUse of non-steroidal anti-inflammatory drugs and risk of Parkinson's disease: nested case-control study.Non-steroidal anti-inflammatory drug use and the risk of Parkinson's disease.The distinct roles of cyclooxygenase-1 and -2 in neuroinflammation: implications for translational research.Eicosanoid receptor subtype-mediated opposing regulation of TLR-stimulated expression of astrocyte glial-derived neurotrophic factor.Towards a pathway definition of Parkinson's disease: a complex disorder with links to cancer, diabetes and inflammation.Parkinson's disease: evidence for environmental risk factors.Osteoarthritis of the hand II: chemistry, pharmacokinetics and pharmacodynamics of naproxen, and clinical outcome studies.Non-Steroidal Anti-Inflammatory Drugs in Alzheimer's Disease and Parkinson's Disease: Reconsidering the Role of Neuroinflammation.Targeting Microglial Activation States as a Therapeutic Avenue in Parkinson's Disease.Inflammatory mechanisms of neurodegeneration in toxin-based models of Parkinson's disease.Polymer brain-nanotherapeutics for multipronged inhibition of microglial α-synuclein aggregation, activation, and neurotoxicity.Updates on immunity and inflammation in Parkinson disease pathology.Sodium salicylate protects against rotenone-induced parkinsonism in rats.Preceding pain symptoms and Parkinson's disease: a nationwide population-based cohort study.NSAID use and risk of Parkinson disease: a population-based case-control studyNonsteroidal anti-inflammatory drugs use and risk of Parkinson disease: A dose-response meta-analysis
P2860
Q22241651-9E8DF24A-D54A-43AB-82CF-B89F70C43F50Q24235107-EF095CBD-E192-469B-88DD-35441B4B500EQ24594751-F1F3C498-CF8E-4896-AAC8-195FBC9888B4Q26795984-6B11A1E4-5B3D-4402-8E29-7EA6F3CB7615Q26801035-6E525F5A-D330-4DF0-87B7-91DE3A0E77DAQ27024667-FFF250D2-1E9C-40BC-8A01-40EE337B1A96Q33718730-29E0B4C8-BEE2-4C8A-B17B-CE8ACE42765AQ34104938-AD9D8537-FFAF-47F3-B26B-1FF1F8C0AE9CQ34505182-DCF4C894-908C-41ED-A251-865046CB8461Q34985170-A3B1B53E-F23B-46C9-AA5D-333CC0CC5551Q36048230-863BEFAE-9997-47FF-A18F-C71C5ADA2622Q36055556-283E6921-4714-45F4-8E1F-804394220BB4Q36453886-3BE24CD3-B4E0-49ED-B945-D1C30CB42151Q38055457-31AC3B07-3A61-4673-B43F-B111F636201EQ38157117-B256188B-DA04-4F28-9E1D-63304A7C475FQ38974344-883C8009-A641-45C0-A634-9F6C9A9CA502Q39392775-6635783C-7F12-4073-B576-73DC3372F46AQ41917715-E720A079-6016-45F0-8B94-86447E0ADDE6Q45814729-C9C601E6-D1E2-4366-ABFF-8B65E9DC080AQ46132067-0549208E-7196-4DEB-BB1F-880138183232Q48145970-D3D9BEFF-2790-4E71-AFF7-B06E87E72327Q48474282-447B3FD4-B42C-4A72-8E8C-9DE539255C0AQ57950713-F8336648-4197-45C7-A186-53A09C3FCE1DQ58739806-AC31B82A-285C-4500-8F08-9DCA1801281B
P2860
Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease
description
2007 nî lūn-bûn
@nan
2007 թուականին հրատարակուած գիտական յօդուած
@hyw
2007 թվականին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease
@ast
Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease
@en
Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease
@nl
type
label
Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease
@ast
Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease
@en
Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease
@nl
prefLabel
Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease
@ast
Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease
@en
Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease
@nl
P2093
P2860
P356
P1433
P1476
Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease
@en
P2093
Bruno H C Stricker
Lonneke M L de Lau
Marjolijn Bornebroek
Mendel D M Haag
Monique M B Breteler
Peter J Koudstaal
P2860
P356
10.1159/000108110
P407
P577
2007-01-01T00:00:00Z